Search Results - "RATTO KIM, S."

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial by Kim, JH, Kamasuta, C, Trichavaroj, R, Kaewkungwal, J, Chantakulkij, S, Ratto-Kim, S, Eamsila, C, Sukwit, S, Nitayaphan, S, Pitsuttihum, P, Michael, NL, Chiu, J, Rerks-Ngarm, S, de Souza, MS, Paris, RM

“…Doc number: O30…”
Get full text

OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial by de Souza, MS, Trichavaroj, R, Schuetz, A, Chuenarom, W, Phuang-ngem, Y, Jongrakthaitae, S, Ratto-Kim, S, Nitayaphan, S, Dally, L, Rerks-Ngam, S, Tartaglia, J, Francis, D, Michael, NL, Paris, RM, Kim, JH

“…Peripheral blood mononuclear cells (PBMC) or plasma were tested to CRF 01_AE and subtype B vaccine antigens in the following validated assays: (1)…”
Get full text

S011-05 OA. HLA-A7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania by Koehler, R N, Walsh, A M, Saathoff, E, Currier, J R, Bautista, C T, Moqueet, N, Ratto-Kim, S, Maboko, L, Hoelscher, M, Robb, M L, Michael, N L, McCutchan, F E, Kim, J H, Kijak, G H

Get full text

HIV DNA and cognition in a Thai longitudinal HAART initiation cohort : The SEARCH 001 Cohort Study by VALCOUR, V. G, SHIRAMIZU, B. T, PAUL, R. H, SHIKUMA, C. M, SITHINAMSUWAN, P, NIDHINANDANA, S, RATTO-KIM, S, ANANWORANICH, J, SIANGPHOE, U, KIM, J. H, DE SOUZA, M, DEGRUTTOLA, V

“…The extent to which highly active antiretroviral therapy (HAART) era cognitive disorders are due to active processes, incomplete clearance of reservoirs, or…”
Get full text

Distinct gene expression profiles associated with the susceptibility of pathogen-specific CD4+ T cells to HIV-1 infection by Hu, H, Nau, M, Ehrenberg, P, Chenine, A, Daye, Z, Wei, Z, Michael, N, Vahey, M, Kim, J, Marovich, M, Ratto-Kim, S

“…Doc number: O46…”
Get full text

Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene by O'Connell, RJ, Polonis, VR, Ratto-Kim, S, Cox, J, Jagodzinski, LL, Malia, J, Michael, NL, Excler, J, Robb, ML, Kim, JH

“…Doc number: O50…”
Get full text

Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection by VALCOUR, V. G, SITHINAMSUWAN, P, CHUENCHITRA, T, ROBERTSON, K. R, PAUL, R. H, MCARTHUR, J. C, KIM, J. H, SHIKUMA, C. M, NIDHINANDANA, S, THITIVICHIANLERT, S, RATTO-KIM, S, APATEERAPONG, W, SHIRAMIZU, B. T, DESOUZA, M. S, CHITPATIMA, S. T, WATT, G

“…HIV-associated dementia (HAD) is not firmly established in patients with circulating recombinant form (CRF) 01_AE HIV-1. In this study, we compared…”
Get full text

OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial by Currier, JR, De Souza, M, Ratto-Kim, S, Paris, R, Nguay, V, Cox, J, Earl, P, Moss, B, Sriplienchan, S, Thongcharoen, P, Kim, J, Robb, M, Michael, N, Marovich, M

Get full text

HIV-Associated Wasting in the Era of Highly Active Antiretroviral Therapy: A Syndrome of Residual HIV Infection in Monocytes and Macrophages? by Shikuma, Cecilia M., Valcour, Victor G., Ratto-Kim, Silvia, Williams, Andrew E., Souza, Scott, Gerschenson, Mariana, Day, Larry, Kim, Jerome H., Shiramizu, Bruce

“…Human immunodeficiency virus (HIV) infection in peripheral blood mononuclear cells (PBMCs) might be influencing the development of wasting in the era of potent…”
Get full text

Discordant plasma and cerebral spinal fluid cytokines/chemokines in relation to HIV-1-associated dementia by Killebrew, D A, Troelstrup, D, Valcour, V, Williams, A, Aguon, J, Sapalo, D, Shikuma, C, Ratto-Kim, S, Shiramizu, B

“…Monocytes and macrophages serve as HIV-1 reservoirs and may indirectly lead to HIV-1-associated dementia via neurotoxic cytokine/chemokine production. It…”
Get more information

Inhibition of Human Immunodeficiency Virus Type 1 gp120 Presentation to CD4 T Cells by Antibodies Specific for the CD4 Binding Domain of gp120 by Hioe, C E, Tuen, M, Chien, Jr, P C, Jones, G, Ratto-Kim, S, Norris, P J, Moretto, W J, Nixon, D F, Gorny, M K, Zolla-Pazner, S

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function by McDonald, R A, Mayers, D L, Chung, R C, Wagner, K F, Ratto-Kim, S, Birx, D L, Michael, N L

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART by Eller, Michael A., Hong, Ting, Creegan, Matthew, Nau, Martin E., Sanders-Buell, Eric, Slike, Bonnie M., Krebs, Shelly J., Ratto-Kim, Silvia, McElrath, M. Juliana, Katabira, Elly T., Bolton, Diane L., Michael, Nelson L., Robb, Merlin L., Tovanabutra, Sodsai, Baeten, Jared M., Sandberg, Johan K.

“…OBJECTIVE:Activated (CD38HLA-DR) PD-1 CD4 T cells are strongly associated with virus replication and disease progression in untreated HIV-1 infection, and…”
Get full text

Circulating proviral HIV DNA and HIV-associated dementia by SHIRAMIZU, Bruce, GARTNER, Suzanne, WILLIAMS, Andrew, SHIKUMA, Cecilia, RATTO-KIM, Silvia, WATTERS, Michael, AGUON, Joleen, VALCOUR, Victor

“…Individuals continue to develop HIV-1-associated dementia (HAD) despite treatment with highly active antiretroviral therapy (HAART). Monocytes/macrophages…”
Get full text

Expansion of restricted cellular immune responses to HIV‐1 envelope by vaccination: IL‐7 and IL‐12 differentially augment cellular proliferative responses to HIV‐1 by KIM, J. H., LOVELAND, J. E., SITZ, K. V., RATTO KIM, S., MCLINDEN, R. J., TENCER, K., DAVIS, K., BURKE, D. S., BOSWELL, R. N., REDFIELD, R. R., BIRX, D. L.

“…The failure of immune effector mechanisms to control HIV‐1 infection has important consequences for the human host. In a randomized cohort of HIV‐infected…”
Get full text

A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine: ALVAC-HIV (vCP1521) Prime With Oligomeric gp160 (92TH023/LAI-DID) or Bivalent gp120 (CM235/SF2) Boost by Thongcharoen, Prasert, Suriyanon, Vinai, Paris, Robert M, Khamboonruang, Chirasak, de Souza, Mark S, Ratto-Kim, Silvia, Karnasuta, Chitraporn, Polonis, Victoria R, Baglyos, Lynn, Habib, Raphaelle El, Gurunathan, Sanjay, Barnett, Susan, Brown, Arthur E, Birx, Deborah L, McNeil, John G, Kim, Jerome H

“…BACKGROUND:The development of an effective HIV-1 vaccine is critical to control the pandemic. A prime-boost HIV-1 vaccine trial assessing safety and…”
Get full text

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults by Nitayaphan, Sorachai, Pitisuttithum, Punnee, Karnasuta, Chitraporn, Eamsila, Chirapa, de Souza, Mark, Morgan, Patricia, Polonis, Victoria, Benenson, Michael, VanCott, Tom, Ratto-Kim, Silvia, Kim, Jerome, Thapinta, Darawan, Garner, Robin, Bussaratid, Valai, Singharaj, Pricha, el Habib, Raphaelle, Gurunathan, Sanjay, Heyward, William, Birx, Deborah, McNeil, John, Brown, Arthur E.

“…ALVAC-HIV (vCP1521) and AIDSVAX B/E were evaluated in a phase 1/2 trial of human immunodeficiency virus (HIV)- negative Thai adults. Of 133 volunteers…”
Get full text

Adoptive transfer of costimulated CD4 + T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection by Levine, Bruce L, June, Carl H, Bernstein, Wendy B, Aronson, Naomi E, Schlienger, Katia, Cotte, Julio, Perfetto, Steven, Humphries, Mary J, Ratto-Kim, Silvia, Birx, Deborah L, Steffens, Carolyn, Landay, Alan, Carroll, Richard G

“…To study the safety and feasibility of T-cell reconstitution in HIV-infected individuals, we adoptively transferred activated autologous CD4+ T cells…”
Get full text

Single-Cell Level Response of HIV-Specific and Cytomegalovirus-Specific CD4 T Cells Correlate With Viral Control in Chronic HIV-1 Subtype A Infection by Eller, Michael A, Eller, Leigh Anne, Ratto-Kim, Silvia, Ouma, Benson J, Lo, Vicky, de Souza, Mark, Guwatudde, David, Nails, Barbara, Michael, Nelson L, Wabwire-Mangen, Fred, Robb, Merlin L, Marovich, Mary A, Sandberg, Johan K, Currier, Jeffrey R

“…BACKGROUND AND OBJECTIVE:HIV-1 subtype A is the second most prevalent subtype globally and is associated with reduced viral load, higher CD4 absolute counts,…”
Get full text

HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: The SEARCH 001 Cohort Study by Valcour, V G, Shiramizu, B T, Sithinamsuwan, P, Nidhinandana, S, Ratto-Kim, S, Ananworanich, J, Siangphoe, U, Kim, J H, de Souza, M, Degruttola, V, Paul, R H, Shikuma, C M

“…Objectives: The extent to which highly active antiretroviral therapy (HAART) era cognitive disorders are due to active processes, incomplete clearance of…”
Get full text